DYP-688 | m-entrepreneurship.com

Product Name :
DYP-688

Search keywords :
GNAQ

drugId :
null

Target Vo:
Guanine nucleotide-binding protein G(q) subunit alpha

Target Vo Short Name :
GNAQ

Moa_Name:
Guanine nucleotide-binding protein G(q) subunit alpha inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Novartis Pharma Ag

Active Indication_Name:
Uveal melanoma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-c-Myc(Ser62) Antibody
STAT3 Antibody (YA666)
CARM1 Antibody (YA812): CARM1 Antibody (YA812) is a non-conjugated and Mouse origined monoclonal antibody about 66 kDa, targeting to CARM1 (2B9). It can be used for WB,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts